Zenas Biopharma Inc (NASDAQ: ZBIO) on Monday, soared 33.08% from the previous trading day, before settling in for the closing price of $23.9. Within the past 52 weeks, ZBIO’s price has moved between $5.83 and $29.73.
The company achieved an average annual earnings per share of 67.57%. With a float of $9.87 million, this company’s outstanding shares have now reached $42.09 million.
Zenas Biopharma Inc (ZBIO) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Zenas Biopharma Inc is 89.08%, while institutional ownership is 37.31%. The most recent insider transaction that took place on Oct 09 ’25, was worth 1,200,002. In this transaction Director of this company bought 63,158 shares at a rate of $19.00, taking the stock ownership to the 1,173,395 shares. Before that another transaction happened on Oct 09 ’25, when Company’s 10% Owner bought 126,315 for $19.00, making the entire transaction worth $2,399,985. This insider now owns 1,917,895 shares in total.
Zenas Biopharma Inc (ZBIO) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -5.02 earnings per share (EPS) for the period topping the consensus outlook (set at -9.3) by 4.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.92 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 67.57% per share during the next fiscal year.
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
Zenas Biopharma Inc (ZBIO) is currently performing well based on its current performance indicators. A quick ratio of 5.23 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 89.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.23, a number that is poised to hit -1.03 in the next quarter and is forecasted to reach -4.72 in one year’s time.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
Compared to the last year’s volume of 0.23 million, its volume of 0.95 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 60.47%.
During the past 100 days, Zenas Biopharma Inc’s (ZBIO) raw stochastic average was set at 90.05%, which indicates a significant increase from 83.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.31 in the past 14 days, which was higher than the 1.63 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $21.06, while its 200-day Moving Average is $12.70. Nevertheless, the first resistance level for the watch stands at $36.02 in the near term. At $40.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $46.15. If the price goes on to break the first support level at $25.89, it is likely to go to the next support level at $19.98. Should the price break the second support level, the third support level stands at $15.76.
Zenas Biopharma Inc (NASDAQ: ZBIO) Key Stats
Market capitalization of the company is 1.34 billion based on 42,110K outstanding shares. Right now, sales total 5,000 K and income totals -156,990 K. The company made 10,000 K in profit during its latest quarter, and -33,570 K in sales during its previous quarter.
